Member Info for shatter

Yep, it would be great to get a special divi but unfortunately Aviva keep going down the share buy back route so we see little or no direct benefit ! Live in hope..

And reasonable volume...

What about a takeover at 40p ? That should firm up the sp...

What a difference a week makes. As Spikeyj says can it be sustained?

Good call on your sells. A few more locked in for the foreseeable. Always dodgy buying on a no news rise..

Volume well down today. Rise on speculation and drop after news or in this case no news ! The sp rise has been very welcome and if we can hold in and around the 10-11p before an update in March I for one will be very pleased.

Well played. A profit is not a profit until it�s in your mits. This appears to be a feel good factor rise with no real substance behind it ! Hopefully 10p maybe the new low before meaningful financial news but who knows ?

Well played. A profit is not a profit until it�s in your mits. This appears to be a feel good factor rise with no real substance behind it ! Hopefully 10p maybe the new low before meaningful financial news but who knows ?

No news, financial or otherwise so expect a retrace.....hope I�m wrong...

The answer I believe is yes!

Must agree. This has the performance of a snail and the market is definitely not happy with Aviva. On paper it looks fine if not bullish but as you say the city is not impressed...

A member of my family lived with Myeloma for over 10 years . I wish you all the best with your treatment.

This month or next ?

Very welcome regardless of the reason..

Peel Hunt predicted 13p back in October but the Times mention seems to have driven volumes significantly . Been here for longer than I care to remember so I expect this run to fizzle out in the short term. For profit takers this is a welcome rise. Nothing wrong with banking profit. G.l.

Would also be very happy with a bid... otherwise not sure were a sustainable increase in the sp is going to come from in the short term..

Over on other sites it is being muted that Oxb needs to raise further funds hence the sp movement ? but from their July statement .... 31 July 2017, the Group held cash amounting to £22.1 million. The Directors are of the opinion that the Group has sufficient working capital for its present requirements, that is for at least 12 months from the date of this announcement. The Directors therefore consider it appropriate to adopt the going concern basis of accounting in preparing the interim financial information. Good volume today but probably no real reason for the rise other than Oxb is in the news at the moment. A couple of days could see a reversal in fortunes. Let’s see what Novartis can do for us this year !

Iain Dey Oxford BioMedica Backing British biotech has served me well this year, so I am going to attempt to repeat the trick. Medicine is making quicker advances than the general public seems to acknowledge. One biotech that seems to offer upside, with limited downside, is Oxford BioMedica. Having more than doubled this year to 8.85p on the back of test results that showed one of its treatments could help cure a form of childhood leukaemia, it is not necessarily an obvious choice for 2018. Nonetheless, Peel Hunt and Jefferies both have a price target of 13p per share, implying more than 40% upside. Formal approval of the aforementioned leukaemia treatment could lead to a reappraisal of what some analysts reckon could be a $1bn blockbuster.

:-)

Can’t see a reverse in fortunes for Pets in the short term so we may see your £1.40s.